insights_auto
Outlook: 36.8% bullish·15.8% bearish
Go to analysischevron_right
CL:NYSE
Colgate-Palmolive Company
$93.39
arrow_downward
-0.77%(-0.72) 1D
$93.39
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 19, 4:00:09 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CL...
Open
$93.04
High
$93.73
Low
$92.86
Mkt. cap
74.45B
Avg. vol.
5.27M
Volume
3.48M
Dividend
2.27%
Quarterly dividend
$0.53
Ex-dividend date
Oct 20, 2026
P/E ratio
36.94
52-wk high
$99.33
52-wk low
$74.54
EPS
$2.53
Beta
0.33
Shares outstanding
797.17M
No. of employees
34K
Open
$93.04
High
$93.73
Low
$92.86
Mkt. cap
74.45B
Avg. vol.
5.27M
Volume
3.48M
Dividend
2.27%
Quarterly dividend
$0.53
Ex-dividend date
Oct 20, 2026
P/E ratio
36.94
52-wk high
$99.33
52-wk low
$74.54
EPS
$2.53
Beta
0.33
Shares outstanding
797.17M
No. of employees
34K
News stories
From web sources and news partners
Zacks
·
6 hours ago
Procter & Gamble's Innovation Push: Catalyst for Long-Term Growth?
Zacks
·
6 hours ago
NWL Sees Broad-Based Sales Recovery: What's Behind the Shift?
MarketBeat
·
12 hours ago
Colgate-Palmolive Company $CL Holdings Raised by Robertson Stephens Wealth Management LLC
ad-hoc-news.de
·
13 hours ago
Bank of America cuts target for Colgate-Palmolive stock to USD 100
Profile
The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products. Wikipedia
About Colgate-Palmolive Company
CEONoel R. Wallace
Employees33.6K
Founded1806
HeadquartersNew York, New York, United States
SectorHousehold goods
Websitecolgatepalmolive.com
Analyst ratings
Based on 12 analysts giving stock ratings to CL in the past 3 months
Buy
Buy
8
Hold
4
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for CL in the last 3 months.
Highest
Current $93.39
$106.00 (+13.50%)
Average
$98.33 (+5.29%)
Lowest
$87.00 (-6.84%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Andrea Faria Teixeira J.P. Morgan | Buy | Reiterated | $104.00 | +11.4% | 10/19/2026 |
Lauren Lieberman Barclays | Hold | Reiterated | $87.00 | -6.8% | 10/16/2026 |
Peter Grom UBS | Buy | Reiterated | $106.00 | +13.5% | 10/15/2026 |
Peter Galbo Bank of America Securities | Buy | Maintained | $100.00 | +7.1% | 10/09/2026 |
Nik Modi RBC Capital | Buy | Maintained | $104.00 | +11.4% | 10/06/2026 |
Bonnie Herzog Goldman Sachs | Buy | Reiterated | $100.00 | +7.1% | 10/05/2026 |
Christopher Carey Wells Fargo | Hold | Maintained | $90.00 | -3.6% | 10/05/2026 |
Michael Lavery Piper Sandler | Buy | Maintained | $95.00 | +1.7% | 09/21/2026 |
Unknown Analyst Bernstein | Hold | Maintained | $99.00 | +6% | 09/15/2026 |
Stephen Powers Deutsche Bank | Buy | Reiterated | $101.00 | +8.1% | 08/03/2026 |
Dara Mohsenian Morgan Stanley | Buy | Reiterated | $104.00 | +11.4% | 08/03/2026 |
Robert Moskow TD Cowen | Hold | Reiterated | $90.00 | -3.6% | 08/03/2026 |
Filippo Falorni Citi | Buy | Maintained | $110.00 | +17.8% | 07/14/2026 |
Cristian Rios Bernstein | Hold | Initiated | $96.00 | +2.8% | 06/11/2026 |
Taylor Conrad Argus Research | Hold | Maintained | - | - | 06/09/2026 |
Robert Ottenstein Evercore ISI | Buy | Maintained | $100.00 | +7.1% | 06/08/2026 |
Andy Sim DBS | Hold | Maintained | $95.00 | +1.7% | 05/03/2026 |
Kaumil Gajrawala Jefferies | Hold | Maintained | $88.00 | -5.8% | 04/21/2026 |
Edward Lewis Rothschild & Co Redburn | Buy | Upgraded | $100.00 | +7.1% | 04/21/2026 |
Next call in 11 days
Fri, Oct 30, 2:30 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.93
Revenue / Est. (USD)
- / 5.34B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 5.13B | 5.23B | 5.32B | 5.36B |
Cost of goods sold | 2.08B | 2.08B | 2.10B | 2.06B |
Cost of revenue | 2.08B | 2.08B | 2.10B | 2.06B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 1.99B | 2.00B | 2.09B | 2.14B |
Operating expense | 2.01B | 2.08B | 2.11B | 2.17B |
Total operating expenses | 4.09B | 4.16B | 4.21B | 4.24B |
Operating income | 1.04B | 1.07B | 1.11B | 1.12B |
Other non operating income | - | - | - | - |
EBT including unusual items | 992.00M | 108.00M | 892.00M | 950.00M |
EBT excluding unusual items | 992.00M | 1.04B | 1.07B | 1.08B |
Income tax expense | 226.00M | 113.00M | 211.00M | 231.00M |
Effective tax rate | 22.78% | 104.63% | 23.65% | 24.32% |
Other operating expenses | 19.00M | 77.00M | 21.00M | 30.00M |
Net income | 735.00M | -37.00M | 646.00M | 693.00M |
Net profit margin | 14.32% | -0.71% | 12.13% | 12.93% |
Earnings per share | 0.91 | 0.95 | 0.97 | 0.99 |
Interest and investment income | 21.00M | 19.00M | 16.00M | 17.00M |
Interest expense | -67.00M | -64.00M | -62.00M | -62.00M |
Net interest expenses | -46.00M | -45.00M | -46.00M | -45.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 1.20B | 1.24B | 1.27B | 1.28B |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1